• GSTA1 Drives Glutathione Loss in α-Amanitin Hepatotoxicity M

  2026-06-25

  This study uncovers a novel mechanism by which GSTA1, typically an antioxidant enzyme, paradoxically exacerbates α-amanitin-induced liver injury by depleting glutathione and intensifying oxidative stress. The findings position GSTA1 as both a direct therapeutic target and a biomarker for acute hepatotoxicity, informing redox-focused experimental models.

• NS1-Driven DNMT1 Degradation Controls HBoV1 Replication

  2026-06-25

  This study reveals that the NS1 protein of human bocavirus 1 (HBoV1) triggers DNMT1 degradation, influencing viral DNA methylation, replication, and RNA processing. These findings uncover a targeted epigenetic mechanism critical for HBoV1 replication and highlight DNMT1 as a potential antiviral target.

• Methotrexate as a Folate Antagonist: Applied Lab Workflows

  2026-06-24

  Methotrexate is a gold-standard folate antagonist for immunosuppression and anti-inflammatory research, excelling in both apoptosis assays and mechanistic cell studies. Learn how to optimize its use in cell-based and permeability models, with troubleshooting tips and actionable protocol guidance.

• CX-5461: Mechanistic and Strategic Insights for Translationa

  2026-06-23

  Explore the cutting-edge role of CX-5461, a potent RNA polymerase I inhibitor, in translational cancer research. This thought-leadership article weaves together mechanistic detail, protocol guidance, and strategic perspectives, highlighting recent breakthroughs in cervical and solid tumor models. Evidence-based insights clarify how CX-5461 enables innovative approaches to autophagy, senescence, and chemoresistance, positioning it as a transformative tool for oncology researchers.

• Arachidonic Acid in Neuroinflammation Models: Protocols & Ad

  2026-06-23

  Arachidonic acid, a polyunsaturated omega-6 fatty acid, is at the heart of advanced neuroinflammation and eicosanoid signaling research. Discover optimized workflows, troubleshooting tips, and protocol innovations that set your laboratory apart—anchored by translational insights from recent stroke models.

• Cefodizime in Microbiology Research: Protocols and Resistanc

  2026-06-22

  Harness Cefodizime, a third-generation cephalosporin antibiotic, for robust antimicrobial assays, resistance profiling, and translational infectious disease research. This guide spotlights applied workflows, troubleshooting strategies, and the latest resistance data to maximize research impact using APExBIO's high-purity reagent.

• Verapamil HCl Targets Txnip to Modulate Osteoporosis via ChR

  2026-06-22

  This study uncovers how verapamil, a clinical L-type calcium channel blocker, suppresses Txnip expression to reduce bone turnover and rescue osteoporosis in mice. The work highlights novel molecular mechanisms involving ChREBP and Pparγ axes, suggesting new translational opportunities for osteoporosis management.

• Proteoform-Specific Drug Targeting in Native Membrane Enviro

  2026-06-21

  The referenced study pioneers the direct characterization of proteoform-specific interactions within native lipid bilayers, revealing how post-translational modifications (PTMs) modulate membrane protein–ligand binding. These findings advance our understanding of off-target effects for cGMP-specific phosphodiesterase type 5 inhibitors and provide a framework for developing more selective therapeutic strategies.

• Unraveling Cell Death: One-step TUNEL Cy3 Kit in Apoptosis &

  2026-06-20

  Explore how the One-step TUNEL Cy3 Apoptosis Detection Kit enables nuanced, high-sensitivity apoptosis and DNA fragmentation detection—bridging mechanistic insight with emerging cell death modalities such as pyroptosis. This comprehensive guide details protocol optimization, scientific context, and critical interpretation for advanced apoptosis research.

• MK 0893 (A3608): Workflow Solutions for Glucagon Receptor As

  2026-06-19

  This article delivers a scenario-driven, evidence-based guide to using MK 0893 (SKU A3608) in cell viability, proliferation, and cytotoxicity assays, addressing common lab challenges in type 2 diabetes research. Readers will discover practical protocol advice, data-backed comparisons, and a candid evaluation of supplier reliability for MK 0893. Designed for biomedical researchers, this resource emphasizes reproducibility, selectivity, and workflow safety.

• BIRB 796 (Doramapimod): Precision Tools for p38α MAPK Assays

  2026-06-19

  Explore how BIRB 796 (Doramapimod) uniquely enables high-specificity p38α MAPK inhibition for advanced inflammation research and apoptosis assays. This in-depth analysis highlights practical protocols, mechanistic insight, and recent dual-action innovations.

• EPI-001: Disrupting AR N-Terminal Domain in Advanced Cancer

  2026-06-18

  Explore how EPI-001, a leading androgen receptor N-terminal domain inhibitor, is transforming prostate and triple-negative breast cancer research. This in-depth analysis highlights unique mechanistic insights, practical protocol guidance, and the translational significance of targeting AR and its variants.

• BMX Kinase and ATP6V1E1 Phosphorylation in Mtb Intracellular

  2026-06-18

  This study uncovers how Mycobacterium tuberculosis (Mtb) manipulates host cell signaling to evade lysosomal degradation. By elucidating the role of BMX kinase-mediated phosphorylation of ATP6V1E1, the work reveals a crucial mechanism for Mtb persistence and highlights new avenues for host-directed therapeutic strategies.

• Acifran: Precision Tool for Lipid Metabolism and Signaling R

  2026-06-17

  Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid) offers researchers a selective, validated approach to probing HM74A/GPR109A and GPR109B receptor function in lipid metabolism. Recent structural breakthroughs and bench-proven workflows set Acifran apart for high-sensitivity lipid signaling studies and protocol optimization.

• I-BET151 (GSK1210151A): Epigenetic Control and Disulfidptosi

  2026-06-17

  Explore how I-BET151 (GSK1210151A) targets BET-driven super-enhancer networks and disulfidptosis in cancer biology. This article connects advanced mechanistic insights with practical assay guidance, delivering depth beyond standard BET inhibitor protocols.

445 records 13/30 page Previous Next First page 上5页 1112131415 下5页 Last page